FINWIRES · TerminalLIVE
FINWIRES

US Oil Update: Crude Prices Surge Over 4% Following UAE's Historic OPEC Exit

作者

-- Crude oil futures jumped more than 4% on Wednesday as the energy market absorbed the impact of the UAE's official withdrawal from OPEC.

The Brent futures contract jumped over 5% to $116.90 per barrel, and West Texas Intermediate futures climbed 5% to $104.93 per barrel.

The surge follows a historic blow to the global oil cartel as the UAE officially announced its withdrawal from OPEC and OPEC+, effective May 1.

Energy Minister Suhail Al Mazrouei confirmed the move was a "policy-driven evolution" aimed at bypassing production quotas to rebuild global reserves and monetize the country's expanded capacity.

"The UAE's exit from OPEC is a big blow to the group, though it will have little impact on the market in the short term amid ongoing supply disruptions. Clearly, there may be more upside to oil supply post-Iran war," ING analysts said.

Despite the structural shift in OPEC, the primary price driver remains the instability in the Persian Gulf and the status of the Strait of Hormuz.

While President Trump claimed via social media that the Iranian administration is collapsing and eager to negotiate, he simultaneously directed aides to prepare for a prolonged naval blockade.

"With no signs of an imminent restart in oil flows we have revised higher our oil forecasts for the remainder of the year. We now expect ICE Brent to average $104/bbl in 2Q26 and $92/bbl in 4Q26," ING added.

相关文章

Australia

瑞银表示,星巴克将保持销售增长势头,下半年将重点关注利润率。

瑞银周三在一份报告中指出,星巴克 (SBUX) 有望在其转型战略的推动下保持强劲的销售势头,但投资者关注的焦点正转向下半年的利润率复苏。 瑞银表示,第二季度强劲的交易驱动型同店销售增长反映了运营改善、菜单创新和更新的会员计划。 展望未来,瑞银表示,持续推进下午饮品平台、会员计划升级、门店关闭和运营改进等举措应能支撑下半年的销售增长。 瑞银还预计,在销售杠杆、成本节约以及关税和咖啡成本压力缓解的推动下,星巴克的利润率将在今年晚些时候有所提升。 瑞银将星巴克的目标股价从100美元上调至105美元,但维持“中性”评级。Price: $106.10, Change: $+8.82, Percent Change: +9.06%

$SBUX
Australia

美国银行证券上调评级后,Elevance Health股价上涨

周三,Elevance Health (ELV) 股价上涨 2.5%,此前美国银行证券将该股评级从“中性”上调至“买入”,目标价为 435 美元。 成交量约为 140 万股,低于日均 190 万股以上。Price: $371.74, Change: $+9.00, Percent Change: +2.48%

$ELV
Australia

Wedbush将Biogen的目标股价从191美元上调至196美元,理由是“催化引擎正在加速运转”,并维持中性评级。

根据FactSet调查的分析师报告,百健(BIIB)的平均评级为“增持”,平均目标价为213.79美元。 (报道北美、亚洲和欧洲主要银行及研究机构的股票、商品和经济研究。研究机构可通过以下链接联系我们:https://www..com/contact-us)Price: $195.08, Change: $+11.70, Percent Change: +6.38%

$BIIB